Table 2 Diagnosis of patient in relation to staining intensity and distribution for CD56.
No | Diagnosis | Intensity | Distribution |
|---|---|---|---|
1 | Biliary atresia | 1 | 1 |
2 | Biliary atresia | 2 | 2 |
3 | Biliary atresia | 3 | 3 |
4 | Biliary atresia | 2 | 2 |
5 | Biliary atresia | 2 | 2 |
6 | Biliary atresia | 3 | 3 |
7 | Biliary atresia | 2 | 2 |
8 | Biliary atresia | 0 | 0 |
9 | Biliary atresia | 2 | 3 |
10 | Biliary atresia | 1 | 2 |
11 | Biliary atresia | 3 | 3 |
12 | Biliary atresia | 3 | 3 |
13 | Biliary atresia | 3 | 3 |
14 | Biliary atresia | 0 | 0 |
15 | Biliary atresia | 3 | 1 |
16 | Biliary atresia | 2 | 3 |
17 | Biliary atresia | 1 | 1 |
18 | PFIC, TYPE III | 1 | 2 |
19 | PFIC, TYPE III | 1 | 1 |
20 | PFIC, TYPE III | 1 | 2 |
21 | Cholestatic hepatitis of unknown etiology | 1 | 2 |
22 | Cholestatic hepatitis of unknown etiology | 0 | 0 |
23 | Cholestatic hepatitis of unknown etiology | 2 | 3 |
24 | Cystic fibrosis | 3 | 3 |
25 | Cystic fibrosis | 1 | 3 |
26 | Inborn error of metabolism | 2 | 3 |
27 | Inborn error of metabolism | 2 | 3 |
28 | Neonatal (Giant cell) hepatitis | 2 | 3 |
29 | Neonatal (Giant cell) hepatitis | 0 | 0 |